Home > Healthcare & Medical Devices > Diabetic Foot Ulcers and Pressure Ulcers Market
Diabetic Foot Ulcers and Pressure Ulcers Market size is anticipated to expand between 2021 and 2027 led by the emergence of advanced biological therapies. The rising complications of diabetes mellitus have steered the surge in concerns over avoiding amputation and surgeries.
Diabetic foot and pressure ulcers are mainly chronic wounds that share similar pathogeneses. The swelling geriatric population and growing prevalence of diabetes will anchor the market growth.
The limitations of skilled healthcare infrastructure and professionals coupled with the higher costs related to ulcer management may restrict the market proliferation. However, the ease of access to explicit dressings for treating specific types of foot ulcers and the extending need for abridged mobility & shortened hospital stays could represent ample growth opportunities for the industry.
With regards to wounds, the market is segmented into diabetic foot ulcer and pressure ulcer. The diabetic foot ulcer is likely to observe significant prominence on account of the growing concerns amongst the diabetic population. The non-availability of preventive measures will also infuse a positive scenario for the industry dynamics.
Based on treatment, the diabetic foot ulcers and pressure ulcers market size from wound care dressings is expected to rise due to an increase in post-treatment infection complications and the higher obligation for reduced hospital stays. The growing need for the effective healing of the transplanted skin has resulted in the mounting awareness of wound care management. The deployment of several advanced technologies for the emergence of newer dressings will further foster the segment growth.
In terms of end-use segmentation, the diabetic foot ulcers and pressure ulcers market share from the hospital segment will attain considerable traction. This can be attributed to the rising financial capacities of these healthcare establishments. The presence of advanced technological devices, as well as trained professionals, are other paramount factors driving the market progression.
North America is set to emerge as a lucrative market revenue pocket for diabetic foot and pressure ulcers over 2021-2027 owing to the growing elderly population and hike in the number of surgical procedures in the region. The rising prevalence of diabetes is a prominent trend supporting regional growth. According to the CDC (Centers for Disease Control and Prevention), approximately 34.2 million individuals in the U.S. suffer from diabetes. The mounting healthcare consumer spending and the robust presence of advanced biological therapies will further lead to industry growth.
Some of the major diabetic foot ulcers and pressure ulcers market participants include 3M Healthcare, Coloplast A/S, Medtronic Plc., Smith & Nephew Plc., Organogenesis, Inc., B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), ConvaTec, Inc., BSN Medical GMBH (Essity), Molnlycke Health Care AB, and Acelity L.P. Inc.
These companies are constantly working towards technological developments and are taking up efforts on marketing strategies, such as acquisitions, partnerships, and investments, for enhancing their product and customer portfolio.
For instance, in June 2018, Organogenesis Inc. announced its plans of supporting the American Diabetes Association (ADA) for the production of an ADA scientific compendium that focuses on the latest scientific evidence pertaining to the treatment of DFU (diabetic foot ulcers).
The present coronavirus crisis contributed to ructions in the global economy whilst drawing a significant impact on the operational activities of almost all the industrial verticals worldwide. However, in regard to the higher frequency of diabetes in COVID-19 patients and the rising complications of foot ulceration, the diabetic foot ulcers and pressure ulcers industry saw a significant boom. The considerable reductions in hospitalizations to tend to diabetic foot problems and their potential complications made way for the higher need for appropriate treatment to the infected patients in the safety of their homes.
Market, by Ulcer type
Market, by Treatment
Market, by End-use
The above information is provided for the following regions and countries: